Vinva Investment Management Ltd Sells 19,760 Shares of Ventas, Inc. $VTR

Vinva Investment Management Ltd decreased its stake in shares of Ventas, Inc. (NYSE:VTR) by 70.1% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 8,431 shares of the real estate investment trust’s stock after selling 19,760 shares during the quarter. Vinva Investment Management Ltd’s holdings in Ventas were worth $583,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently modified their holdings of VTR. BI Asset Management Fondsmaeglerselskab A S grew its position in Ventas by 97.7% in the 3rd quarter. BI Asset Management Fondsmaeglerselskab A S now owns 36,713 shares of the real estate investment trust’s stock valued at $2,570,000 after purchasing an additional 18,146 shares during the period. Investment Management Corp of Ontario raised its holdings in Ventas by 1,019.0% during the second quarter. Investment Management Corp of Ontario now owns 133,061 shares of the real estate investment trust’s stock worth $8,403,000 after buying an additional 121,170 shares during the last quarter. Hudson Bay Capital Management LP bought a new position in shares of Ventas in the second quarter valued at $17,568,000. SCS Capital Management LLC bought a new position in shares of Ventas in the second quarter valued at $13,788,000. Finally, Y Intercept Hong Kong Ltd grew its holdings in shares of Ventas by 28.5% during the third quarter. Y Intercept Hong Kong Ltd now owns 83,524 shares of the real estate investment trust’s stock valued at $5,846,000 after buying an additional 18,527 shares during the last quarter. Institutional investors and hedge funds own 94.18% of the company’s stock.

Insider Buying and Selling

In related news, CEO Debra A. Cafaro sold 10,322 shares of the stock in a transaction dated Monday, February 2nd. The shares were sold at an average price of $77.66, for a total transaction of $801,606.52. Following the completion of the transaction, the chief executive officer owned 1,114,034 shares in the company, valued at approximately $86,515,880.44. This represents a 0.92% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Robert F. Probst sold 29,930 shares of the firm’s stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of $77.25, for a total transaction of $2,312,092.50. Following the sale, the chief financial officer owned 138,434 shares of the company’s stock, valued at $10,694,026.50. This trade represents a 17.78% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 86,106 shares of company stock valued at $6,931,397. 1.00% of the stock is owned by insiders.

Ventas Price Performance

Ventas stock opened at $86.00 on Wednesday. The stock has a market cap of $40.85 billion, a P/E ratio of 159.26, a P/E/G ratio of 2.10 and a beta of 0.73. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 1.03. The company’s 50 day moving average price is $80.93 and its two-hundred day moving average price is $76.06. Ventas, Inc. has a 52 week low of $60.15 and a 52 week high of $87.87.

Ventas (NYSE:VTR) last issued its quarterly earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 EPS for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). Ventas had a net margin of 4.31% and a return on equity of 2.09%. The business had revenue of ($1,229.71) million for the quarter, compared to analysts’ expectations of $1.53 billion. During the same period in the previous year, the business posted $0.81 earnings per share. The business’s revenue was up 21.7% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. On average, equities analysts predict that Ventas, Inc. will post 3.4 earnings per share for the current year.

Ventas Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, April 16th. Investors of record on Tuesday, March 31st will be issued a $0.52 dividend. This is an increase from Ventas’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. Ventas’s payout ratio is presently 355.56%.

Wall Street Analyst Weigh In

VTR has been the topic of a number of analyst reports. Argus set a $88.00 target price on shares of Ventas in a report on Tuesday, February 10th. Cantor Fitzgerald reiterated an “overweight” rating and set a $93.00 price target on shares of Ventas in a research note on Monday, February 9th. UBS Group reissued a “neutral” rating and set a $85.00 price objective on shares of Ventas in a report on Monday, February 9th. Jefferies Financial Group reissued a “buy” rating and issued a $93.00 price objective on shares of Ventas in a research note on Monday, December 15th. Finally, The Goldman Sachs Group reaffirmed a “buy” rating and set a $100.00 target price on shares of Ventas in a research report on Monday, February 9th. Thirteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $89.00.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.